G

Glenmark Pharmaceuticals Ltd
NSE:GLENMARK

Watchlist Manager
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Watchlist
Price: 1 552.1 INR 0.1%
Market Cap: 438B INR
Have any thoughts about
Glenmark Pharmaceuticals Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

122.5B
+2%
Revenue
Growth Rates:
1 Year
-42%
3 Years
+4%
5 Years
+19%
7 Years
+27%
10 Years
+89%
9.5B
+20%
Operating Income
Growth Rates:
1 Year
-56%
3 Years
-46%
5 Years
-24%
7 Years
-40%
10 Years
-1%
-8.8B
+33%
Net Income
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Earnings Waterfall
Glenmark Pharmaceuticals Ltd

Revenue
122.5B INR
Cost of Revenue
-42.1B INR
Gross Profit
80.4B INR
Operating Expenses
-70.9B INR
Operating Income
9.5B INR
Other Expenses
-18.2B INR
Net Income
-8.8B INR

Income Statement
Glenmark Pharmaceuticals Ltd

Rotate your device to view
Income Statement
Currency: INR
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
64 730
N/A
65 725
+2%
66 298
+1%
68 055
+3%
70 342
+3%
70 545
+0%
76 496
+8%
79 071
+3%
82 218
+4%
90 352
+10%
91 857
+2%
95 793
+4%
96 118
+0%
92 805
-3%
91 031
-2%
89 057
-2%
92 304
+4%
95 817
+4%
98 655
+3%
100 227
+2%
102 564
+2%
104 370
+2%
106 410
+2%
106 629
+0%
108 004
+1%
108 516
+0%
109 439
+1%
115 641
+6%
117 590
+2%
121 456
+3%
123 049
+1%
121 172
-2%
123 450
+2%
126 355
+2%
115 832
-8%
214 584
+85%
212 906
-1%
203 334
-4%
118 131
-42%
120 212
+2%
122 476
+2%
Gross Profit
Cost of Revenue
(19 779)
(19 966)
(22 376)
(19 718)
(20 198)
(19 405)
(26 923)
(23 727)
(23 900)
(25 123)
(30 216)
(27 121)
(28 485)
(30 311)
(35 520)
(30 759)
(32 055)
(32 859)
(39 293)
(34 136)
(35 189)
(35 832)
(42 088)
(36 969)
(37 515)
(37 366)
(43 272)
(40 295)
(41 324)
(42 929)
(49 788)
(42 584)
(42 815)
(43 757)
(46 984)
(77 781)
(78 092)
(76 754)
(50 030)
(43 357)
(42 079)
Gross Profit
44 950
N/A
45 759
+2%
43 922
-4%
48 338
+10%
50 145
+4%
51 141
+2%
49 573
-3%
55 344
+12%
58 319
+5%
65 230
+12%
61 641
-6%
68 672
+11%
67 631
-2%
62 492
-8%
55 510
-11%
58 297
+5%
60 249
+3%
62 958
+4%
59 362
-6%
66 091
+11%
67 375
+2%
68 537
+2%
64 322
-6%
69 659
+8%
70 488
+1%
71 150
+1%
66 167
-7%
75 346
+14%
76 267
+1%
78 528
+3%
73 261
-7%
78 589
+7%
80 635
+3%
82 598
+2%
68 849
-17%
136 803
+99%
134 814
-1%
126 580
-6%
68 101
-46%
76 856
+13%
80 397
+5%
Operating Income
Operating Expenses
(35 400)
(37 245)
(34 733)
(40 330)
(41 514)
(41 442)
(37 937)
(43 686)
(46 268)
(49 387)
(47 039)
(52 200)
(51 868)
(51 259)
(42 877)
(47 909)
(49 294)
(50 820)
(46 763)
(53 656)
(54 954)
(56 291)
(51 501)
(55 715)
(55 618)
(55 471)
(49 759)
(57 980)
(58 719)
(59 387)
(54 861)
(62 010)
(64 068)
(67 193)
(58 191)
(113 953)
(113 414)
(113 318)
(61 966)
(68 970)
(70 903)
Selling, General & Administrative
(11 826)
(12 256)
(26 980)
(12 120)
(12 551)
(12 835)
(30 389)
(14 642)
(15 482)
(16 050)
(35 412)
(16 532)
(17 280)
(17 922)
(36 245)
(19 399)
(19 886)
(20 258)
(31 881)
(20 903)
(21 710)
(22 251)
(32 544)
(22 776)
(22 913)
(23 307)
(32 424)
(24 305)
(24 175)
(24 069)
(33 742)
(24 874)
(25 311)
(27 011)
(36 238)
(47 690)
(47 709)
(47 680)
(39 563)
(28 973)
(29 510)
Depreciation & Amortization
(2 515)
(2 559)
(2 600)
(2 540)
(2 584)
(2 556)
(2 691)
(2 865)
(2 941)
(3 102)
(5 765)
(5 878)
(5 982)
(6 089)
(3 541)
(3 457)
(3 408)
(3 344)
(3 259)
(3 373)
(3 490)
(3 719)
(4 172)
(4 397)
(4 496)
(4 588)
(4 436)
(4 435)
(4 626)
(4 663)
(4 867)
(5 204)
(5 529)
(5 963)
(5 692)
(10 292)
(10 150)
(9 997)
(5 819)
(5 577)
(5 365)
Other Operating Expenses
(21 059)
(22 430)
(5 154)
(25 670)
(26 380)
(26 052)
(4 856)
(26 179)
(27 844)
(30 233)
(5 862)
(29 789)
(28 605)
(27 248)
(3 091)
(25 053)
(26 000)
(27 218)
(11 623)
(29 380)
(29 754)
(30 320)
(14 785)
(28 540)
(28 208)
(27 576)
(12 900)
(29 242)
(29 919)
(30 656)
(16 251)
(31 933)
(33 228)
(34 220)
(16 261)
(55 971)
(55 556)
(55 640)
(16 585)
(34 421)
(36 029)
Operating Income
9 552
N/A
8 515
-11%
9 188
+8%
8 008
-13%
8 630
+8%
9 699
+12%
11 636
+20%
11 658
+0%
12 051
+3%
15 842
+31%
14 602
-8%
16 472
+13%
15 765
-4%
11 235
-29%
12 634
+12%
10 389
-18%
10 955
+5%
12 139
+11%
12 599
+4%
12 436
-1%
12 422
0%
12 247
-1%
12 821
+5%
13 945
+9%
14 871
+7%
15 679
+5%
16 409
+5%
17 366
+6%
17 548
+1%
19 141
+9%
18 400
-4%
16 578
-10%
16 567
0%
15 404
-7%
10 658
-31%
22 849
+114%
21 399
-6%
13 263
-38%
6 134
-54%
7 885
+29%
9 493
+20%
Pre-Tax Income
Interest Income Expense
(1 928)
(1 968)
(3 450)
(1 839)
(1 755)
(1 711)
(1 713)
(1 800)
(2 003)
(2 151)
(2 192)
(2 652)
(2 721)
(2 809)
(2 766)
(2 937)
(3 090)
(3 270)
(3 104)
(3 485)
(3 532)
(3 608)
(3 584)
(3 781)
(3 689)
(3 682)
(3 342)
(3 349)
(3 232)
(2 945)
(1 508)
(2 825)
(2 967)
(3 273)
(979)
(6 410)
(6 794)
(7 164)
(4 743)
(4 439)
(3 710)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(24)
0
1 672
1 672
1 672
1 672
0
0
329
609
640
774
445
165
134
(1 784)
(2 609)
(2 609)
(2 609)
(486)
(7 659)
(7 840)
(11 094)
(12 200)
(9 010)
(8 489)
(5 235)
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
0
0
0
(12)
0
0
0
4
0
0
0
(65)
0
0
0
57
0
0
0
15
0
0
Total Other Income
(25)
(55)
205
88
86
86
124
905
879
1 003
192
(233)
82
(295)
825
2 143
3 245
2 387
1 833
714
126
1 546
1 407
2 164
1 037
858
310
503
691
679
194
2 912
4 017
4 642
320
4 824
3 867
3 557
7 968
8 518
8 895
Pre-Tax Income
7 598
N/A
6 491
-15%
5 943
-8%
6 257
+5%
6 961
+11%
8 075
+16%
10 047
+24%
10 764
+7%
10 928
+2%
14 694
+34%
12 602
-14%
13 587
+8%
13 125
-3%
8 130
-38%
10 668
+31%
9 593
-10%
12 781
+33%
12 926
+1%
13 006
+1%
11 337
-13%
9 014
-20%
10 184
+13%
10 961
+8%
12 939
+18%
12 860
-1%
13 630
+6%
13 825
+1%
14 685
+6%
15 141
+3%
15 091
0%
14 412
-4%
14 057
-2%
15 009
+7%
16 289
+9%
2 398
-85%
13 424
+460%
7 379
-45%
(2 545)
N/A
365
N/A
3 474
+852%
9 444
+172%
Net Income
Tax Provision
(1 522)
(1 411)
(1 190)
(1 445)
(1 822)
(2 380)
(3 028)
(3 473)
(3 420)
(4 291)
(3 442)
(3 353)
(3 042)
(1 711)
(2 925)
(2 776)
(3 867)
(3 783)
(3 756)
(3 325)
(2 587)
(3 011)
(3 201)
(3 732)
(3 868)
(4 065)
(4 124)
(4 458)
(4 506)
(4 541)
(4 476)
(5 075)
(5 988)
(6 757)
(3 294)
(8 248)
(6 793)
(4 273)
(18 673)
(18 757)
(19 379)
Income from Continuing Operations
6 076
5 081
4 752
4 813
5 140
5 695
7 019
7 291
7 507
10 402
9 159
10 233
10 083
6 420
7 743
6 818
8 915
9 143
9 250
8 013
6 428
7 173
7 760
9 206
8 991
9 565
9 701
10 226
10 634
10 550
9 936
8 983
9 022
9 532
(896)
5 176
586
(6 818)
(18 309)
(15 283)
(9 935)
Income to Minority Interest
16
(3)
1
1
0
0
2
1
1
0
0
0
0
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
(171)
(349)
(519)
(705)
(716)
(720)
(802)
(1 397)
(1 419)
(1 443)
(681)
(449)
(248)
Net Income (Common)
6 092
N/A
5 078
-17%
4 753
-6%
4 815
+1%
5 142
+7%
5 697
+11%
7 021
+23%
7 292
+4%
7 507
+3%
10 401
+39%
9 160
-12%
10 233
+12%
10 083
-1%
6 420
-36%
7 742
+21%
6 817
-12%
8 914
+31%
9 143
+3%
9 250
+1%
8 013
-13%
6 428
-20%
7 173
+12%
7 760
+8%
9 206
+19%
8 991
-2%
9 565
+6%
9 701
+1%
10 227
+5%
10 464
+2%
10 201
-3%
9 417
-8%
8 277
-12%
8 304
+0%
8 811
+6%
2 972
-66%
9 802
+230%
6 378
-35%
139
-98%
(15 017)
N/A
(13 113)
+13%
(8 752)
+33%
EPS (Diluted)
22.47
N/A
18.72
-17%
17.52
-6%
17.07
-3%
18.23
+7%
20.27
+11%
25
+23%
25.76
+3%
26.62
+3%
36.88
+39%
32.48
-12%
36.28
+12%
35.75
-1%
22.76
-36%
27.45
+21%
24.16
-12%
31.59
+31%
32.42
+3%
32.8
+1%
28.41
-13%
22.78
-20%
25.42
+12%
27.5
+8%
32.63
+19%
31.88
-2%
33.9
+6%
34.4
+1%
36.26
+5%
37.1
+2%
36.17
-3%
33.39
-8%
29.35
-12%
29.44
+0%
31.24
+6%
10.53
-66%
34.71
+230%
22.57
-35%
0.49
-98%
-53.21
N/A
-46.47
+13%
-31
+33%

See Also

Summary
GLENMARK intrinsic value, competitors valuation, and company profile.
DCF Valuation
GLENMARK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GLENMARK stock valuation using valuation multiples.
Wall Street Estimates
GLENMARK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GLENMARK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.